TrialHuman vaccines & immunotherapeutics2025

Safety and immunogenicity of Ad26.COV2.S in adolescents: Phase 2 randomized clinical trial.

Jelena Tica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.